McAdam LLC’s Allergan plc AGN Stock Holding History

McAdam LLC’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-18	Closed	-$3K	–	703
2018 Q3	$3K	Hold	18	–	–	﹤0.01%	495
2018 Q2	$3K	Hold	18	–	–	﹤0.01%	475
2018 Q1	$3K	Buy	+18	New	+$3.02K	﹤0.01%	498

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

McAdam LLC's AGN Position: Q4 2018 in Review

McAdam LLC sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 18 shares — an estimated $3K sold.

McAdam LLC first reported a position in AGN in Q1 2018 and held it in 3 quarters. The position peaked at $3K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

McAdam LLC reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 18 Allergan plc shares in Q4 2018, an estimated $3K.
McAdam LLC first reported a position in Allergan plc in Q1 2018 and held it in 3 quarters.
McAdam LLC's Allergan plc position peaked at $3K in Q3 2018.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.